Scarica l'app Stockscreener
0.9001
0.77%
-0.007
Dopo l'orario di chiusura:
.93
0.0299
+3.32%
Precedente Chiudi:
$0.9071
Aprire:
$0.9099
Volume 24 ore:
153.91K
Relative Volume:
0.53
Capitalizzazione di mercato:
$93.45M
Reddito:
-
Utile/perdita netta:
$-19.50M
Rapporto P/E:
-5.9217
EPS:
-0.152
Flusso di cassa netto:
$-19.09M
1 W Prestazione:
-11.75%
1M Prestazione:
-9.99%
6M Prestazione:
+20.82%
1 anno Prestazione:
+36.90%
Intervallo 1D:
$0.89
$0.93
Intervallo di 1 settimana:
$0.89
$1.26
Portata 52W:
$0.41
$1.74
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Nome
Tiziana Life Sciences Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-12-22 | Iniziato | B. Riley Securities | Buy |
| 2018-12-17 | Iniziato | Laidlaw | Buy |
Tiziana Life Sciences Ltd Borsa (TLSA) Ultime notizie
Tiziana Life Sciences CEO discusses foralumab potential to enhance OzempicICYMI - Proactive Investors USA
Tiziana Life Sciences to showcase breakthrough therapies at BIO-Europe 2024 Conference - Proactive Investors UK
Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data - The Manila Times
Tiziana Life Sciences secures funding to advance development of MS and Alzheimer’s therapy - Proactive Investors USA
Tiziana Life Sciences Plans Share Sale with Jefferies - MSN
Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study - GlobeNewswire
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million - The Manila Times
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million - GlobeNewswire Inc.
Tiziana reports progress in obesity inflammation study By Investing.com - Investing.com South Africa
Tiziana Life Sciences : announces plans for clinical development of foralumab, the company’s fully human CD3 antibody - Marketscreener.com
Tiziana Life Sciences' Semaglutide combo shows potential in obesity-related liver inflammation - Proactive Investors USA
TLSATiziana Life Sciences Ltd. Common Shares Latest Stock News & Market Updates - StockTitan
Tiziana Life Sciences reports promising preclinical results for novel combination therapy targeting obesity - Proactive Investors UK
Tiziana reports progress in obesity inflammation study - Investing.com
Proactive news headlines: Helix, Hemogenyx, DEC, Ananda, Thor Energy, Bradda Head and more - Proactive Investors UK
Discover October 2024's Promising US Penny Stocks - Simply Wall St
Micron Technology (MU-Q) QuotePress Release - The Globe and Mail
Tiziana Life Sciences Advances with Promising Drug Trials - Yahoo Finance
Tiziana Life Sciences reports interim results, updates on programs - Investing.com India
Tiziana Life Sciences reports interim results, updates on programs By Investing.com - Investing.com Canada
Tiziana Life Sciences Ltd Reports Earnings Results for the Half Year Ended June 30, 2024 - Marketscreener.com
Tiziana Life Sciences Ltd (NASDAQ:TLSA) Short Interest Update - MarketBeat
High Affinity Nerve Growth Factor Receptor Market constantly growing to See Bigger Picture - IndiaPolitics.com
Thymic Carcinoma Treatment Market Size, Market Resilience and Forecasted Scenarios (2024-2034) - Third Eye News
Short Interest in Tiziana Life Sciences Ltd (NASDAQ:TLSA) Declines By 67.0% - MarketBeat
Base Resources Limited (OTCMKTS:BSRUF) Sees Significant Increase in Short Interest - Defense World
Tiziana Life Sciences Secures $4M Grant for Alzheimer’s Disease Study - European Pharmaceutical Manufacturer
EverSource Wealth Advisors LLC Acquires 330,000 Shares of Signing Day Sports, Inc. (NYSEAMERICAN:SGN) - Defense World
New Pacific Mtl to Post Q1 2025 Earnings of $0.00 Per Share, Raymond James Forecasts (TSE:NUA) - Defense World
iShares ESG Aware MSCI USA ETF (NASDAQ:ESGU) Stock Holdings Lifted by Affinity Capital Advisors LLC - Defense World
Short Interest in SciSparc Ltd. (NASDAQ:SPRC) Increases By 691.3% - Defense World
Affinity Capital Advisors LLC Has $4.62 Million Position in Vanguard Short-Term Bond ETF (NYSEARCA:BSV) - Defense World
ENN Energy Holdings Limited (OTCMKTS:XNGSY) Short Interest Up 550.0% in September - Defense World
Thrivent Financial for Lutherans Cuts Holdings in Regal Rexnord Co. (NYSE:RRX) - Defense World
AlTi Global Inc. Sells 1,052 Shares of CVS Health Co. (NYSE:CVS) - Defense World
Tiziana Life Sciences Ltd: Analyzing TLSA Stock Trends - The InvestChronicle
JPMorgan Chase & Co. Initiates Coverage on Alcoa (NYSE:AA) - Defense World
Tesla's Massive October Starts Next Week With Third-Quarter Deliveries - MSN
CRH plc (NYSE:CRH) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Large Increase in Short Interest - Defense World
Tesla's Robotaxi Launch: A Game-Changer For Stock Performance? - MSN
Tesla (TSLA) call put ratio 2.1 calls to 1 put with focus on October 285 and 325 calls into deliveries release for Q3 and Robotaxi meeting - StreetInsider.com
Commonwealth Financial Services LLC Acquires 95 Shares of Tesla, Inc. (NASDAQ:TSLA) - Defense World
Tesla: stock outperforms, buoyed by optimism from UBS - Marketscreener.com
Analysts praise groundbreaking Tesla rival, previews Robotaxi event - MSN
Tesla Stock Pops 5% To 2-Month High As Q3 Deliveries, Robotaxi Event Await - MSN
Edge Capital Group LLC Acquires New Holdings in Tesla, Inc. (NASDAQ:TSLA) - Defense World
Morse Asset Management Inc Raises Position in Tesla, Inc. (NASDAQ:TSLA) - Defense World
Lombard Odier Asset Management Europe Ltd Increases Holdings in Tesla, Inc. (NASDAQ:TSLA) - Defense World
Tesla, Inc. (NASDAQ:TSLA) Shares Sold by Quest Investment Management LLC - Defense World
Circle Wealth Management LLC Increases Stock Position in Tesla, Inc. (NASDAQ:TSLA) - Defense World
Tiziana Life Sciences Ltd Azioni (TLSA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):